Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Russian firm HSCI wins race to bring first gene therapy to market in Europe

This article was originally published in Scrip

Executive Summary

A Russian biotech firm has become the first company to get a gene therapy approved for commercial use in Europe. However, the product has only been approved in Russia and it is unlikely it would receive an easy ride to EMA or FDA approval in Europe or the US, should its developer decide to pursue this.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel